To include your compound in the COVID-19 Resource Center, submit it here.

Forest Laboratories generics, pharmaceuticals news

Forest defeated a challenge from activist investor Carl Icahn as shareholders elected all 10 of Forest's proposed directors by a "significant margin" at the annual meeting, the company said, citing

Read the full 308 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE